American Capital Ltd. (ACAS) announced that it has committed $212 million in the One Stop Buyout of Cambridge Major Laboratories, Inc. or , a global provider of complex chemistry-based outsourcing services to the pharmaceutical and biotechnology industries. CML expands American Capital's portfolio of healthcare products and services companies, which have aggregate revenues of over $600 million.
American Capital's investment took the form of debt and preferred and common equity.
In a separate press release, American Capital announced Thursday that in the fourth quarter of 2012, it made open market purchases of approximately 8.8 million shares of American Capital common stock, or 2.8% of the company's outstanding shares as of September 30, 2012. The shares were purchased at an average price of $11.72 per share, totaling approximately $103 million.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org